Literature DB >> 22388697

Therapy: Silencing inhibitors of bone formation.

Katrina Ray.   

Abstract

Year:  2012        PMID： 22388697     DOI： 10.1038/nrrheum.2012.17

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.

Authors:  Ge Zhang; Baosheng Guo; Heng Wu; Tao Tang; Bao-Ting Zhang; Lizhen Zheng; Yixin He; Zhijun Yang; Xiaohua Pan; Heelum Chow; Kinwah To; Yaping Li; Dahu Li; Xinluan Wang; Yixiang Wang; Kwongman Lee; Zhibo Hou; Nan Dong; Gang Li; Kwoksui Leung; Leungkim Hung; Fuchu He; Lingqiang Zhang; Ling Qin
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

Review 2.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694
  2 in total
  1 in total

Review 1.  Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.

Authors:  Kazuki Sawamoto; J Víctor Álvarez; Angélica María Herreño; Francisco J Otero-Espinar; Maria L Couce; Carlos J Alméciga-Díaz; Shunji Tomatsu
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.